% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Zitricky:286640,
      author       = {F. Zitricky and A. I. Koskinen and O. Hemminki and A.
                      Försti$^*$ and A. Hemminki and K. Hemminki$^*$},
      title        = {{S}urvival in oral and pharyngeal cancers is catching up
                      with laryngeal cancer in the {NORDIC} countries through a
                      half century.},
      journal      = {Cancer medicine},
      volume       = {13},
      number       = {1},
      issn         = {2045-7634},
      address      = {Hoboken, NJ},
      publisher    = {Wiley},
      reportid     = {DKFZ-2024-00008},
      pages        = {e6867},
      year         = {2024},
      note         = {#LA:Z999# / 2024 Jan 2;13(1):e6867},
      abstract     = {Cancers of the head and neck (HN) are heterogeneous tumors
                      with incidence rates varying globally. In Northern Europe
                      oral and oropharyngeal cancers are the most common
                      individual types. Survival for HN varies by individual tumor
                      type but for most of them survival trends are not well known
                      over extended periods of time.Data for a retrospective
                      survival study were obtained for Danish, Finnish, Norwegian,
                      and Swedish patients from the NORDCAN database from 1971 to
                      2020. Relative 1- and 5-year survival rates and 5/1-year
                      conditional survival for years 2-5 were calculated.Both 1-
                      and 5-year survival improved for all HN cancers but only
                      marginally for laryngeal cancer. For the other cancers a
                      50-year increase in 5-year survival was about $30\%$ units
                      for nasopharyngeal and oropharyngeal cancers, $20\%$ units
                      for oral cancer and somewhat less for hypopharyngeal
                      cancer.5-year survival reached about $65\%$ for all HN
                      cancers, except for hypopharyngeal cancer $(30\%).$ Human
                      papilloma virus infection is becoming a dominant risk factor
                      for the rapidly increasing oropharyngeal cancer, the
                      prevention of which needs to emphasize oral sex as a route
                      of infection.},
      keywords     = {conditional survival (Other) / human papilloma virus
                      (Other) / oral cancer (Other) / pharyngeal cancer (Other)},
      cin          = {B062 / HD01 / Z999},
      ddc          = {610},
      cid          = {I:(DE-He78)B062-20160331 / I:(DE-He78)HD01-20160331 /
                      I:(DE-He78)Z999-20160331},
      pnm          = {313 - Krebsrisikofaktoren und Prävention (POF4-313)},
      pid          = {G:(DE-HGF)POF4-313},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {pmid:38164108},
      doi          = {10.1002/cam4.6867},
      url          = {https://inrepo02.dkfz.de/record/286640},
}